The present invention relates to the treatment of neurodegenerative diseases including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease and Amylotrophic Lateral Sclerosis, comprising the administration of a composition comprising apo-transferrin and holo-transferrin.